Landmark trial
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Wilkins A, Mossop H, Syndikus I, et al.
DoseLab summary
Two-year patient-reported outcomes from the CHHiP trial. Citation as given in the eviQ reference list; not yet checked against the journal.
Why this is useful
Patient-reported bowel, urinary and sexual outcomes from CHHiP; cited by eviQ alongside the main CHHiP report for the 20-fraction constraints.
Reference details
- Title
- Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
- Authors / organization
- Wilkins A, Mossop H, Syndikus I, et al.
- Publication / protocol
- Lancet Oncol. 2015;16(16):1605–1616
- Version
- Pending verification
- Year
- 2015
- DOI
- Pending verification
- Disease sites
- Prostate
- Topics
- Prostate, Hypofractionation, Patient-reported outcomes
- Fractionation context
- CHHiP schedules
- Last reviewed by DoseLab
- Pending verification